Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad
More articles/Ad
More articles
-
Covid-19 has transformed the secondary market in securitization in various ways — from forcing the market to take trading online to shifting the peak trading hours. Panellists at ABS East this week said the changes enacted during the spring sell-offs are here to stay, and traders have already begun to adapt to the new normal. -
Baker Bros Advisors, a shareholder in Chinese biopharmaceutical company BeiGene, has raised $340.1m from a sell-down of the firm’s American depositary shares.
-
JD Health International has raised HK$27bn ($3.5bn) after sealing its IPO at the top end of the marketed range, following a flood of global investor demand.
-
There will be winners and losers among CLO managers as a result of the Covid crisis, leading to consolidation in the sector, IMN's ABS East Virtual 2020 heard this week. Panellists tried to rethink the post-pandemic CLO landscape.
-
Small business lenders may see fewer credit losses on their post-Covid SME loans, thanks to a big tightening in underwriting standards in the wake of the pandemic, said investors speaking on a panel at ABS East Virtual 2020.
-
Europcar is one of the first large companies to restructure with a big state-backed Covid-19 rescue loan in its capital structure. The planned scheme, proposed to creditors last week, leaves the guaranteed loan untouched, which is likely to be the preferred plan for future creditor compacts.
